(HealthDay)—Current smokers are less likely to receive guideline-concordant screening studies for breast, prostate, and colorectal cancer versus never smokers, according to a study published online May 17 in JAMA Network Open.
* This article was originally published here
This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.